The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Dr. Reddy’s Laboratories Ltd. ADR (NYSE: RDY) closed at $13.18 down -2.51% from its previous closing price of $13.52. In other words, the price has decreased by -$2.51 from its previous closing price. On the day, 1.85 million shares were traded.
Ratios:
For a deeper understanding of Dr. Reddy’s Laboratories Ltd. ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.69 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 31.82. For the most recent quarter (mrq), Quick Ratio is recorded 1.37 and its Current Ratio is at 1.92. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.02.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 29 ’24 when Israeli Erez bought 65,500 shares for $82.29 per share.
Valuation Measures:
As of this moment, Dr.’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.14, and their Forward P/E ratio for the next fiscal year is 16.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.95 while its Price-to-Book (P/B) ratio in mrq is 2.96.
Stock Price History:
Over the past 52 weeks, RDY has reached a high of $16.89, while it has fallen to a 52-week low of $12.26. The 50-Day Moving Average of the stock is -0.63%, while the 200-Day Moving Average is calculated to be -10.56%.
Shares Statistics:
A total of 834.42M shares are outstanding, with a floating share count of 833.09M. Insiders hold about 0.00% of the company’s shares, while institutions hold 14.19% stake in the company.
